A 60 year old man with type 2 diabetes and obesity presents for preventive care. His haemoglobin A1c is 7.4 percent on metformin alone. He has no established cardiovascular disease. His estimated 10 year ASCVD risk is 9 percent. According to current guidelines, which blood pressure threshold should prompt initiation of pharmacologic therapy to reduce cardiovascular risk in this patient?